Table 1.

Patients for whom surveillance of hepatocellular carcinoma is recommended according to society guidelines

Cirrhotic patients regardless of etiology, Child-Pugh stage A-B[12-14]
Cirrhotic patients regardless of etiology, Child-Pugh stage C awaiting liver transplantation[12-14]
Asian male hepatitis B carriers over the age of 40 yr[12-14]
Asian female hepatitis B carriers over the age of 50 yr[12-14]
Hepatitis B carriers with a family history of HCC[12-14]
Non-cirrhotic F3 patients, regardless of etiology, may be considered for surveillance based on an individual risk assessment[14]

HCC: Hepatocellular carcinoma.